Stockscreener 앱 받기
41.31
3.07%
1.23
전일 마감가:
$40.08
열려 있는:
$39.62
하루 거래량:
996.38K
Relative Volume:
1.30
시가총액:
$2.59B
수익:
-
순이익/손실:
$-230.66M
주가수익비율:
-9.8965
EPS:
-4.1742
순현금흐름:
$-148.12M
1주 성능:
+7.19%
1개월 성능:
+31.52%
6개월 성능:
+49.03%
1년 성능:
+820.04%
1일 변동 폭
$37.05
$42.18
1주일 범위
$35.77
$42.18
52주 변동 폭
$4.315
$47.84
Kodiak Sciences Inc Stock (KOD) Company Profile
명칭
Kodiak Sciences Inc
전화
650-281-0850
주소
1250 PAGE MILL RD, PALO ALTO, CA
Compare KOD vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KOD
Kodiak Sciences Inc
|
41.31 | 2.59B | 0 | -230.66M | -148.12M | -4.1742 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-10-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-09-22 | 개시 | Jefferies | Buy |
| 2025-08-14 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-12-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-05 | 개시 | H.C. Wainwright | Neutral |
| 2023-12-11 | 재개 | Goldman | Sell |
| 2023-11-17 | 업그레이드 | CapitalOne | Equal Weight → Overweight |
| 2023-07-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-07-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-07-24 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2023-07-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-15 | 개시 | CapitalOne | Overweight |
| 2022-08-02 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-02-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2021-03-12 | 개시 | Evercore ISI | Outperform |
| 2021-03-01 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2021-02-17 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2021-01-25 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-11 | 개시 | Citigroup | Neutral |
| 2020-11-30 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-11-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-13 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-31 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-03 | 개시 | Goldman | Buy |
| 2020-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-02-06 | 개시 | SunTrust | Buy |
| 2020-01-08 | 개시 | ROTH Capital | Buy |
| 2020-01-03 | 개시 | Jefferies | Buy |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-20 | 개시 | Chardan Capital Markets | Buy |
| 2018-10-29 | 개시 | Barclays | Overweight |
| 2018-10-29 | 개시 | BofA/Merrill | Buy |
| 2018-10-29 | 개시 | Morgan Stanley | Overweight |
모두보기
Kodiak Sciences Inc 주식(KOD)의 최신 뉴스
Price to earnings forward of Kodiak Sciences, Inc. – LS:A2N6P0 - TradingView
Kodiak Sciences Inc (KOD) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Kodiak Sciences (KOD) price target increased by 16.91% to 66.30 - MSN
KODIAK SCIENCES INC (KOD) Stock Chart - ChartMill
Kodiak Sciences (KOD) Stages a Bounce: Biotech Stock Gains 3.9% as It Tests Key ResistanceDividend Arbitrage - dars.gov.et
Why Did KOD Stock Surge To A Four-Year High Today? - Stocktwits
Is Kodiak Sciences’ (KOD) Shift Into Russell Growth Indices Reframing Its Core Investment Story? - Sahm
Form 4 Kodiak Sciences Inc For: 2 July By Investing.com - Investing.com Nigeria
Kodiak Sciences (KOD) director receives grant of 17,731 stock options - Stock Titan
Director at Kodiak Sciences (KOD) receives 17,731 stock options award - Stock Titan
[Form 4] Kodiak Sciences Inc. Insider Trading Activity - Stock Titan
17,731 options granted to Kodiak (NASDAQ: KOD) board director - Stock Titan
Kodiak Sciences (KOD) director awarded stock options for 17,731 shares at $38.96 - Stock Titan
17,731 Kodiak Sciences (KOD) options granted tied to Baker funds - Stock Titan
KOD News | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill
Kodiak Sciences Inc Q1 2026 Earnings: EPS Beat Despite Zero Revenue, Stock Gains 3.23%Earnings Call Transcript - dars.gov.et
Kodiak Sciences Inc.(NasdaqGM:KOD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LifeSci Capital Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $65 - Moomoo
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM:KOD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 2000 Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 3000E Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 3000E Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell Microcap Index - marketscreener.com
Enterprise value to EBIT forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to EBITDA forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to book forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to sales forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to revenue forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to earnings forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Kodiak Sciences, Inc. Actuals & Estimates (NASDAQ:KOD) - TradingView
KOD Forecast — Price Target — Prediction for 2027 - TradingView
KODKodiak Sciences Inc Options - Finviz
Kodiak Sciences Inc (KOD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kodiak Sciences Inc (KOD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kodiak Sciences Inc (KOD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kodiak Sciences Inc (KOD) Institutional Confidence - TradingKey
Kodiak Sciences Inc (KOD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kodiak Sciences Inc (KOD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kodiak Sciences Inc (KOD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kodiak Sciences Inc (KOD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kodiak Sciences Inc (KOD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KOD Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress Temps Market SkepticismEarnings Decline Risk - newsline.com
Kodiak Sciences Inc Stock (US50012K1051): Quiet-day stock in focus after no fresh trigger was verifi - Ad-hoc-news.de
Kodiak Sciences: Clinical Redemption Is Turning Into Platform Leverage (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences (KOD) Edges Higher: Biotech Momentum Builds at $34.55ATR Stop - newsline.com
Kodiak stock rises 35% in 3 months: Here's what you need to know - MSN
Kodiak Sciences Inc. - MLQ.ai
Why Kodiak Sciences (KOD) Is Down 15.4% After Zenkuda’s Phase III GLOW2 Win And Accelerated Filing - Sahm
Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus - Sahm
Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans - Yahoo Finance
Kodiak Sciences Inc (KOD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Kodiak Sciences Inc 주식 (KOD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| BORGESON JOHN A. | Chief Financial Officer |
Jun 04 '26 |
Sale |
34.10 |
30,000 |
1,023,009 |
211,930 |
2.64%
자본화:
|
볼륨(24시간):